Cincinnati Children's Hospital Medical Center Logo

Experimental Hematology and Cancer Biology

Loading...

Grants, Contracts, and Industry Agreements

Grant and Contract Awards Annual Direct / Project Period Direct

ANDREASSEN, P

FANCD2 Monobiquitination in DNA Damage Responses
R01 HL 08558707/08/08 - 06/30/13 $225,000 / $1,125,000

BOSCO, E

Training Program in Cancer Therapeutics
T32 CA 11784602/01/07 - 01/31/10 $41,796 / $75,972

CANCELAS, J

Inhibition of Rac GTPases in the Therapy of Chronic Mylogenous Leukemia
W81XWH-07-1-029704/01/07 - 03/31/10 $144,315 / $450,000
Rac in p190-BCR/ABL Leukemia
07/01/07 - 06/30/09 $100,000 / $200,000
Rac GTPase Inhibition in Chronic Myelogenous Leukemia
R01 HL 08715904/06/09 - 02/28/13 $250,000 / $1,000,000

FILIPPI, M

The Role of the Small GTPase RHOA in Hematopoietic Stem Cell Engraftment
SDG0635027N07/01/06 - 06/30/10 $59,091 / $236,364

GEIGER, H

Genomic Integrity and DNA-Repair Pathways in Aging
07/01/05 - 06/30/09 $46,296 / $185,184
Pathways to Mutagenesis in Vivo and in Stem Cells
R01 ES 01269508/15/06 - 06/30/11 $2,609 / $28,207
Young Stem Cell Potential in Aged Mice
R21 DK 07776204/01/08 - 03/31/10 $150,000 / $275,000
Activated Protein C for Treatment of Radiation Combined Injury
R21 AI 08055707/01/08 - 06/30/10 $40,000 / $80,000

GROGG, M

Cdc42GAP in Insulin Signaling in Hepatocytes
F32 DK 08210809/12/08 - 09/11/11 $49,646 / $153,822

GUO, F

Genetic and Biochemical Evaluation of Rac1 GTPase Signaling Mechanism in Primary Cells
BGIA0765194B07/01/07 - 06/30/09 $55,000 / $110,000

LINK, K

Targeting the FLT3 Signaling in MLL-AF9 Leukemia
07/01/08 - 06/30/10 $40,000 / $80,000

MALIK, P

Cincinnati Comprehensive Sickle Cell Center - Project 5
U54 HL 07087106/15/08 - 03/31/12 $389,734 / $1,558,936
CTSA: Stem Cell Research
UL1 RR 02631404/03/09 - 03/31/14 $27,012 / $27,012

MAYES, D

NF1 and Ras Activation in Oligodendrocyte Progenitor Cell Development and Lyelination
FG 1762A107/01/08 - 06/30/11 $45,976 / $143,300

MEETEI, R

Function and Regulation FANCM in Fanconi Anemia
R01 HL 08408205/01/07 - 04/30/12 $250,000 / $1,250,000
Defining the Fanconi Anemia-DNA Repair Pathway by Protein Association Analysis
10/01/07 - 09/30/09 $75,000 / $150,000

MULLOY, J

The Role of CBFb-MYH11 in Acute Myeloid Leukemia
R01 CA 11831904/15/06 - 02/28/11 $257,340 / $887,500
Microenvironment and Flt3 Signaling in MLL Leukemia
06/01/08 - 05/31/11 $68,182 / $204,545

PAN, D

Genetic Engineering for Delivering Large Molecules Across the Blood-Brain Barrier
07/01/08 - 06/30/09 $25,000 / $25,000
Genetic Modification for BBB-Targeted Protein Delivery
R01 NS 06433009/30/08 - 08/31/13 $218,750 / $1,093,750

PANG, Q

Role of FA Protein Complexes In Hematopoiesis
R01 HL 07671207/01/05 - 06/30/09 $237,045 / $1,000,000
Role of Tumor Necrosis Factor in Leukemogenesis
1013-0907/01/08 - 06/30/13 $103,115 / $515,575
Role of NPM in FA Leukemogenesis
12/01/08 - 11/30/10 $40,000 / $80,000

RATNER, N

Mitogenic Activities In Neurofibromatosis
R01 NS 02884003/22/06 - 01/31/11 $280,467 / $1,416,947
Schwann Cells In Neurofibromatosis Type 2 (NF2)
R01 CA 11803208/13/07 - 05/31/12 $190,000 / $950,000
Cincinnati Center for Neurofibromatosis Research
P50 NS 05753109/15/08 - 06/30/13 $1,013,568 / $5,278,047
Ratner, NancyCore A297,941
Cripe, TimothyCore B100,525
Rizvi, TilatCore C81,073
Perentesis, JohnProject 1304,308
Ratner, NancyProject 2204,721
Therapeutic Targets for Peripheral Nerve Tumors
W81XWH-09-1-013503/01/09 - 02/28/11 $219,843 / $439,686
Identification of Drug Targets for NF1
R21 NS 06094002/15/09 - 01/31/11 $10,629 / $21,258

REEVES, L

FDA-NTP Studies of Insertional Mutagenesis
HHSN2912005553609/05/08 - 08/15/09 $92,711 / $132,647

SENGUPTA, A

Rac GTPases and BMI-1 CML Stem Cell Niche
10/01/08 - 09/30/09 $45,717 / $45,717

WEI, J

A Novel Model of Poor Prognosis Infant Leukemia Using Primary Human Blood Stem Cells
07/01/07 - 12/31/08 $50,000 / $100,000

ZHENG, Y

Cell Type and Stimulus-Specific Role of Cdc42 in Blood
R01 HL 08536207/01/06 - 05/31/11 $242,750 / $1,221,000
Rac of GTPases as Targets in Lymphomagenesis
R01 CA 12565802/10/07 - 01/31/12 $190,000 / $950,000
Training Program in Pediatric Hematologic and Oncologic Diseases
T32 HL 09180509/01/08 - 08/31/13 $151,392 / $779,736
Rac GTPase-Specific Small Molecule Inhibitors
R01 CA 14134103/24/09 - 01/31/14 $169,934 / $817,982
Rac GTPases in the Mammalian Brain Development
R01 NS 05643507/01/08 - 06/30/12 $80,000 / $400,000
Current Year Direct6,332,861
Current Year Direct Receipts0
Service Collaborations

Malik, P

$ 54,373
$ 225,793
$ 62,630
$ 66,588
$ 138,839
$ 2,723
$ 24,309
$ 23,959
$ 9,578
$ 1,108
$ 1,278
$ 4,173
$ 3,244
$ 6,329
$ 10,000
$ 3,865
$ 9,189
$ 5,505
$ 1,460
Current Year Direct654,943
Funded Collaborative Efforts

Ratner, N

Cincinnati NF1 Preclniical Testing Center
Cripe, Timothy06/01/09 - 05/31/1110 %

Cancelas, J

Transcriptional Control of Respiratory Epithelial Progenitor Cells
Whitsett, Jeffery08/28/07 - 06/30/1110 %

Pan, D

Cincinnati Comprehensive Sickle Cell Center
Joiner, Clinton06/15/08 - 03/31/1215 %
Total6,332,861